Evoke Pharma Reports First Quarter 2024 Financial Results
14 mai 2024 16h15 HE
|
Evoke Pharma, Inc.
114% year-over-year increase in net product sales70% prescriber growth in Q1 2024 compared to Q4 2023Growing sales metrics reaffirms company’s $14M net revenue guidance for 2024 SOLANA BEACH, Calif.,...
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico
17 janv. 2024 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company
18 déc. 2023 06h00 HE
|
First Wave BioPharma, Inc.
Phase 3-ready latiglutenase, a targeted oral biotherapeutic for celiac disease, will expand First Wave BioPharma’s late-stage gastrointestinal (GI) disease clinical pipeline A concurrent...
Date and Time Announced for First Wave BioPharma CEO James Sapirstein’s Presentation at the 2023 BIO Investor Forum
10 oct. 2023 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Solomon Partners to Expand Healthcare Group with Hiring of Karan Garg (KG) and Brad Hildebrand
02 oct. 2023 11h50 HE
|
Solomon Partners
Solomon Partners to Expand Healthcare Group with Hiring of Karan Garg (KG) and Brad Hildebrand
4.9% CAGR for Gastrointestinal Drugs Market Size Worth $71.3Bn, Globally, by 2027 with Irritable Bowel Syndrome Segment Driving Growth During 2020-2027 | Report by The Insight Partners
11 juil. 2023 10h55 HE
|
The Insight Partners
Pune, India, July 11, 2023 (GLOBE NEWSWIRE) -- The Insight Partners latest study on "Gastrointestinal Drugs Market Size Report, Forecast to 2027 – COVID-19 Impact and Global Analysis – by Drug...
First Wave BioPharma Announces Final Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation
28 juin 2023 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., June 28, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
American College of Gastroenterology and American Gastroenterological Association Invest in Oshi Health to Accelerate Adoption of Hybrid Digestive Health Care
13 juin 2023 09h15 HE
|
Oshi Health
PORTLAND, Ore., June 13, 2023 (GLOBE NEWSWIRE) -- AHIP 2023 CONFERENCE -- Oshi Health today announced strategic investments by the American College of Gastroenterology (ACG) and the American...
Florida Medical Clinic Announces New Gastroenterology Service at Epperson/Watergrass
22 mai 2023 15h53 HE
|
Florida Medical Clinic
TAMPA, Fla., May 22, 2023 (GLOBE NEWSWIRE) -- Florida Medical Clinic announced today that it plans to add a Gastroenterology practice to its new Epperson/Watergrass Campus in July. The...
Oshi Health Raises $30M Series B Funding to Scale Access to Its Virtual Multidisciplinary Digestive Care
11 avr. 2023 08h00 HE
|
Oshi Health
NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) -- Oshi Health, the virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics, today announced that it has raised $30...